Blog

Rifaximin Is the Most Consistently Effective Antibiotic for SIBO and IBS-D, According to a 2026 Review A systematic review published in World Journal of…

A New Path for IBS-C: How Natural Products and Meal Timing Target Root Causes Irritable bowel syndrome with constipation affects millions, often reducin…

Rifaximin shows consistent clinical efficacy for IBS-D patients, reducing symptoms with a relatively low 16.7% adverse event rate

For many with irritable bowel syndrome with constipation (IBS-C), symptom management can be a frustrating search for what works

Here is a comprehensive, evidence-based pillar article on gut health and IBS/SIBO, meticulously crafted per your detailed instructions for maximum autho…

IBS-C Constipation Treatment Management: Integrating Natural Products and Meal Timing Constipation-predominant irritable bowel syndrome (IBS-C) challeng…

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: Overlap, Recurrence, and Evidence-Based Treatment A 2026 systematic review of 55 cli…

Introduction Short-chain fatty acids (SCFAs) like butyrate are not just byproducts of digestion

Evidence-Based IBS-C Constipation Treatment Management Irritable bowel syndrome with constipation (IBS-C) remains a complex challenge, where simple laxa…

A 2026 Systematic Review Clarifies Best Treatments for SIBO-IBS Symptom Overlap In a 2026 systematic review published in World J Methodol , researchers …

Pathophysiology-Driven Natural Products for IBS-C A 2026 review in Naunyn-Schmiedeberg’s Archives of Pharmacology consolidates evidence that certain nat…

A systematic review published in 2026 analyzed 55 clinical trials and found the antibiotic rifaximin to be the most consistently effective treatment for…